Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants.

Infect Dis Ther · 2018 · PMC5840097 · PMID 29149439

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

approached significanceP = .055so close (0.05 < p ≤ 0.1)

Utilization in infants 33–34 wGA decreased over the study period and approached significance ( P = .055); among infants 29–30 wGA, there was no significant change ( P = .815).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.